| Literature DB >> 34295874 |
Zakir Ullah1,2, Kang Kim1, Arramshetti Venkanna1, Hye Su Kim3, Moon Il Kim3, Mi-Hyun Kim1.
Abstract
As a non-covalent interaction of a chiral scaffold in catalysis, pnicogen bonding of ass="Chemical">epi-cinchonidine (Entities:
Keywords: DFT calculation; HOMO–LUMO; UV-Vis spectroscopy; enantiotopic face; pnicogen bonding
Year: 2021 PMID: 34295874 PMCID: PMC8290064 DOI: 10.3389/fchem.2021.669515
Source DB: PubMed Journal: Front Chem ISSN: 2296-2646 Impact factor: 5.221
FIGURE 1Reactive sites of cinchona alkaloids and the representative conformations of epi-cinchonidine (right: syn/anti, open/close; left: optimized geometry with the atomic number).
FIGURE 2Synthetic route of epi-cinchonidine.
Optimized geometric parameters of epi-CD.
| Geometric parameter | Experimental X-ray | B3LYP/6-31G(d,p) | B3LYP/6-311G |
|---|---|---|---|
|
| |||
| O36-H37, C17-O36, C17-H44 | NA, NA, 0.999 | 0.966, 1.427, 1.101 | 0.962, 1.429, 1.098 |
| C17-C18, C17-C9, C18-N43 | 1.535, 1.317, 1.473 | 1.545, 1.522, 1.478 | 1.543, 1.520, 1.477 |
| C6-C1, C4-C3, C22-C29 | 1.413, 1.427, 1.600 | 1.414, 1.435, 1.565 | 1.412, 1.432, 1.565 |
|
| |||
| C17-O36-H37, H44-C17-O36 | NA, NA | 107.66, 108.56 | 107.95, 108.38 |
| C3-N16-C13, C18-N43-C21 | 117.148, 108.047 | 117.15, 112.13 | 117.29, 112.24 |
|
| |||
| H37-O36-C17-C9, C17-C18-N43-C21 | NA, NA | 58.008,80.108 | 59.79, 80.54 |
| H15-C13-N16-C3, C2-C3-N16-C13 | 179.439, 180.000 | 179.808, 179.820 | 179.68, 179.85 |
The experimental values were acquired from CCDC data of the epi-cinchonidine derivative (CCDC ID: 958721). When a corresponding value is not available in the compound, the value is presented as “NA (not available).”
FIGURE 3HOMO and LUMO of epi-cinchonidine.
Simulated IR frequencies (in cm−1) of epi-CD (gas phase) at the B3LYP/6-311+G(d,p) level of theory.
| S: No. | Simulated | Experimental | Approximate assignment |
|---|---|---|---|
| 1 | 3,792 | 3,433 | υ O-H |
| 2 | 3,084, 3,066 | 3,079 | υ C-H (unsym) |
| 3 | 3,025, 3,029 | 3,049 | υ C-H |
| 4 | 1621 | 1639 | υ C-C; β C-H |
| 5 | 1506 | 1450 | υ C-C; Wag C-H |
| 6 | 1116, 1105, 1160 | 1165 | υ C-C, C-O; β C-H, O-H |
| 7 | 917 | 918 | υ C-O, C-N; β C-H |
υ, stretching; β, out-of-plane bending; Wag, wagging; unsym, unsymmetrical.
Experimental and calculated electronic excitations of epi-CD.
| Peak | Calc. λ (nm) | Exp. λ (nm) | Excitation energy (eV) | Oscillator strength | Electronic transition | ||||
| t-zeta | d-zeta | CHCl3 | t-zeta | d-zeta | t-zeta | d-zeta | t-zeta | d-zeta | |
| 1 | 289.14 | 288.83 | 284 | 4.2881 | 4.2926 | 0.1059 | 0.1116 | H−1→L | H−1→L |
| 2 | 235.02 | 222.48 | 237 | 5.2755 | 5.5729 | 0.0156 | 0.6821 | H−5→L | H−1→L1 |
d-zeta, TD-B3LYP/6-31+G(d,p) in the CHCl3 PCM; t-zeta, TD-B3LYP/6-311+G(d,p) in the CHCl3 PCM.
FIGURE 4Geometry analysis of the epi-cinchonidine complex (epi-CD-X1/epi-CD-X2) with the pnicogen bond.
Optimized geometric parameters, ΔEint, ΔEint, CP, QNBO, and QMulliken of X-epi-CD1/X-epi-CD2.
| Entry | X | σI | Es | <C17O36H37 | <C13N16C3 | ΔEint | ΔEint,CP | QNBO | QMulliken |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 107.6 | 0 | 0 | ||||||
| 2 | PH3 | 0 | 0 | 108 | 0.15 | −0.70 | −0.117 | 0.311 | |
| 3 | BrPH2 | 0.5 | −1.16 | 107.8 | −1.44 | −2.58 | −0.028 | 0.096 | |
| 4 | (CF3)PH2 | 0.42 | −2.4 | 107.6 | −1.66 | −2.22 | 0.049 | 0.117 | |
| 5 | (CH3)PH2 | −0.04 | −1.24 | 108 | −0.12 | −0.87 | 0.001 | 0.088 | |
| 6 | ClPH2 | 0.47 | −0.97 | 107.5 | −2.45 | −5.03 | −0.038 | 0.181 | |
| 7 | (CN)PH2 | 0.53 | −0.51 | 108.8 | 0.19 | −1.80 | 0.066 | 0.1 | |
| 8 | FPH2 | 0.52 | −0.46 | 108.6 | −3.21 | −4.81 | −0.037 | 0.072 | |
| 9 | (OH)PH2 | 0.29 | −0.55 | 111 | −5.86 | −7.60 | −0.057 | 0.059 | |
| 10 | (NO2)PH2 | 0.76 | −2.52 | 107.6 | −4.43 | −7.32 | −0.08 | 0.19 | |
| 11 | 117.1 | 0 | 0 | ||||||
| 12 | PH3 | 0 | 0 | 116.3 | −0.25 | −1.25 | −0.467 | −0.17 | |
| 13 | BrPH2 | 0.5 | −1.16 | 118.3 | −7.05 | −9.65 | −0.084 | 0.055 | |
| 14 | (CF3)PH2 | 0.42 | −2.4 | 117.6 | −2.77 | −4.61 | 0.117 | 0.159 | |
| 15 | (CH3)PH2 | −0.04 | −1.24 | 117.4 | −0.29 | −1.42 | 0.055 | 0.109 | |
| 16 | ClPH2 | 0.47 | −0.97 | 117.4 | −1.13 | −2.65 | −0.195 | −0.003 | |
| 17 | (CN)PH2 | 0.53 | −0.51 | 117.3 | −3.64 | −5.43 | −0.295 | −0.063 | |
| 18 | FPH2 | 0.52 | −0.46 | 117.6 | −7.29 | −10.28 | −0.304 | −0.109 | |
| 19 | (OH)PH2 | 0.29 | −0.55 | 118.2 | −10.56 | −12.75 | −0.366 | −0.179 | |
| 20 | (NO2)PH2 | 0.76 | −2.52 | 118.7 | −10.78 | −12.95 | −0.305 | −0.06 |
Taft size parameter.
Orbital energies of the HOMO and LUMO (hartree), band gap (eV), and dipole moment (D) for the X-epi-CD1 complexes.
| No. | X | HOMO | LUMO | Gap | D |
| D(P-O) | D(P-H) |
|---|---|---|---|---|---|---|---|---|
| 1 | PH3 | −0.202 | −0.048 | 4.18 | 2.32 | 168.1 | 3.55 | 2.60 |
| 2 | FPH2 | −0.205 | −0.059 | 3.98 | 1.63 | 152.4 | 3.47 | 2.58 |
| 3 | F2PH | −0.210 | −0.054 | 4.24 | 1.73 | 72.8 | 2.93 | 3.06 |
| 4 | F3P | −0.210 | −0.053 | 4.27 | 2.17 | 72.2 | 2.95 | 3.10 |
| 5 | ClPH2 | −0.207 | −0.062 | 3.94 | 2.29 | 145.6 | 3.61 | 2.76 |
| 6 | Cl2PH | −0.222 | −0.058 | 4.46 | 3.48 | 76.8 | 3.19 | 3.27 |
| 7 | Cl3P | −0.208 | −0.074 | 3.65 | 1.56 | 102.9 | 3.37 | 3.02 |
| 8 | BrPH2 | −0.207 | −0.063 | 3.91 | 1.99 | 147.6 | 3.59 | 2.73 |
| 9 | Br2PH | −0.211 | −0.079 | 3.60 | 2.37 | 89.3 | 3.19 | 3.05 |
| 10 | Br3P | −0.207 | −0.092 | 3.15 | 1.98 | 79.9 | 3.24 | 3.27 |
| 11 | F3CPH2 | −0.217 | −0.056 | 4.38 | 2.76 | 88.6 | 3.28 | 3.16 |
| 12 | (CF3)2PH | −0.209 | −0.052 | 4.26 | 2.30 | 92.0 | 3.30 | 3.12 |
| 13 | (CF3)3P | −0.207 | −0.054 | 4.17 | 1.32 | 98.8 | 3.35 | 3.06 |
| 14 | CNPH2 | −0.217 | −0.057 | 4.35 | 3.58 | 78.3 | 3.01 | 3.05 |
| 15 | (CN)2PH | −0.216 | −0.060 | 4.24 | 3.40 | 70.2 | 2.87 | 3.05 |
| 16 | (CN)3P | −0.214 | −0.087 | 3.45 | 3.40 | 94.4 | 3.49 | 3.28 |
| 17 | O2NPH2 | −0.207 | −0.086 | 3.31 | 4.60 | 85.5 | 3.36 | 3.29 |
| 18 | (NO2)2PH | −0.219 | −0.099 | 3.28 | 4.32 | 71.3 | 2.59 | 3.08 |
| 19 | (NO2)3P | −0.219 | −0.130 | 2.44 | 4.41 | 66.6 | 2.57 | 2.80 |
| 20 | HOPH2 | −0.203 | −0.051 | 4.14 | 2.16 | 163.6 | 3.48 | 2.53 |
| 21 | (OH)2PH | −0.207 | −0.059 | 4.01 | 2.77 | 158.9 | 3.41 | 2.48 |
| 22 | (OH)3P | −0.204 | −0.059 | 3.93 | 1.61 | 160.7 | 3.42 | 2.48 |
| 23 | H3CPH2 | −0.200 | −0.046 | 4.20 | 3.04 | 172.9 | 3.49 | 2.53 |
| 24 | (CH3)2PH | −0.199 | −0.046 | 4.17 | 3.23 | 168.1 | 3.43 | 2.47 |
| 25 | (CH3)3P | −0.199 | −0.047 | 4.14 | 2.94 | 168.4 | 3.40 | 2.43 |
FIGURE 5Predicted full UV-Vis spectrum of the epi-cinchonidine complex: X-axis = wavelength and Y-axis = oscillator strengths and epsilon. Experimental full UV-Vis spectrum of the epi-cinchonidine complex: X-axis = wavelength and Y-axis = observance.
Calculated excitation energies, oscillator strengths, and molecular orbitals (MOs) of CD and CD-X at the TD-B3LYP/6-31+G(d,p) level of theory.
| No. | Species | Peak | Energy (eV) | Calc. λ (nm) | Exp. λ (nm) | Strength | Molecular orbital | Coefficient |
|---|---|---|---|---|---|---|---|---|
| 1 | epi-CD | 1 | 4.2926 | 288.83 | 284 | 0.1116 | H−1→L | 0.68341 |
| 2 | 5.5729 | 222.48 | 237 | 0.6821 | H−1→L1 | 0.46481 | ||
| 2 | MA-CD | 1 | 4.2984 | 288.44 | 285 | 0.1165 | H−1→L | 0.63651 |
| 2 | 5.4281 | 228.41 | 232 | 0.0429 | H−6→L | 0.57214 | ||
| 3 | Br3P-CD1 | 1 | 3.5722 | 347.08 | 318 | 0.0690 | H→L3 | 0.67614 |
| 2 | 4.1844 | 296.30 | 235 | 0.0233 | H−6→L3 | 0.58271 | ||
| 4 | Br3P-CD2 | 1 | 3.8103 | 325.39 | 320 | 0.0874 | H→L6 | 0.50492 |
| 2 | 5.1798 | 239.36 | 235 | 0.0851 | H−5→L2 | 0.49543 | ||
| 5 | Br3P-CD1 | 1 | 3.4699 | 357.32 | 318 | 0.0134 | H→L1 | 0.55407 |
| 2 | 4.2389 | 292.49 | 235 | 0.0472 | H−1→L1 | 0.58319 | ||
| 6 | Br3P-CD2 | 1 | 4.0001 | 309.96 | 320 | 0.0800 | H−4→L | 0.65344 |
| 2 | 4.1378 | 299.64 | 235 | 0.0552 | H−1→L2 | 0.65601 | ||
| 7 | I3As-CD1 | 1 | 2.0623 | 601.19 | 362 | 0.0023 | H→L | 0.70694 |
| 2 | 2.8463 | 435.6 | 292 | 0.0019 | H−1→L | 0.70322 | ||
| 3 | 3.2812 | 377.86 | 232 | 0.019 | H−7→L | 0.67673 | ||
| 8 | I3As-CD2 | 1 | 3.072 | 403.6 | 358 | 0.0189 | H−2→L | 0.60869 |
| 2 | 3.3554 | 369.51 | 288 | 0.0213 | H−7→L | 0.66956 | ||
| 3 | 3.9813 | 311.42 | 233 | 0.0564 | H−7→L1 | 0.48214 | ||
| 9 | I3Sb-CD1 | 1 | 2.4695 | 502.07 | 318 | 0.002 | H→L | 0.7069 |
| 2 | 3.3973 | 364.94 | 250 | 0.0207 | H−3→L | 0.63835 | ||
| 3 | 3.8764 | 319.84 | 232 | 0.0329 | H−1→L2 | 0.66762 | ||
| 10 | I3Sb-CD2 | 1 | 3.332 | 372.1 | 317 | 0.0201 | H−1→L | 0.65117 |
| 2 | 4.0891 | 303.21 | 236 | 0.0722 | H−10→L | 0.41281 | ||
| 11 | I3Bi-CD1 | 1 | 2.1036 | 589.38 | 375 | 0.0045 | H→L | 0.70669 |
| 2 | 4.0479 | 306.29 | 292 | 0.0977 | H−1→L2 | 0.55728 | ||
| 12 | I3Bi-CD2 | 1 | 3.2635 | 379.91 | 363 | 0.0421 | H−1→L | 0.65687 |
| 2 | 3.7971 | 326.52 | 292 | 0.0678 | H−1→L1 | 0.53361 | ||
| 13 | PA-CD1 | 1 | 4.2212 | 293.72 | 316 | 0.103 | H−1→L | 0.68772 |
| 2 | 5.5264 | 224.35 | 235 | 0.6572 | H−1→L1 | 0.50141 | ||
| 14 | PA-CD2 | 1 | 4.1416 | 299.36 | 316 | 0.1062 | H−1→L | 0.69007 |
| 2 | 5.5029 | 225.31 | 230 | 0.7259 | H−1→L1 | 0.52953 |
Basis set was 6–311+G(d,p).
FIGURE 6AIM analysis of the epi-CD-X complex. RDG isosurface maps: (A) PH2CN–OH as a representative X-epi-CD1 (X: PH2CN, OH: O36H37 at C17) and (B) PH2CN–N as a representative X-epi-CD2 (X: PH2CN, N: N16 of quinoline). Display of critical points: (C) PH2CN–OH (as X-epi-CD1) and (D) PH2CN (as X-epi-CD2). NCI plot of the epi-CD-X complex: (E) PH2CN–OH (as X-epi-CD1) and (F) PH2CN (as X-epi-CD2).
FIGURE 7Proposed models of the cinchona alkaloid–catalyzed asymmetric reaction.